Yousif Capital Management LLC Has $7.58 Million Holdings in The Clorox Company $CLX

Yousif Capital Management LLC boosted its stake in The Clorox Company (NYSE:CLX) by 8.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,161 shares of the company’s stock after purchasing an additional 5,012 shares during the quarter. Yousif Capital Management LLC owned about 0.05% of Clorox worth $7,584,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. American National Bank & Trust raised its stake in Clorox by 69.5% during the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after acquiring an additional 89 shares in the last quarter. Ransom Advisory Ltd acquired a new position in Clorox during the first quarter worth about $35,000. GW&K Investment Management LLC raised its stake in Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after acquiring an additional 208 shares in the last quarter. Roble Belko & Company Inc raised its stake in Clorox by 140.7% during the first quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock worth $53,000 after acquiring an additional 211 shares in the last quarter. Finally, IMA Advisory Services Inc. acquired a new position in Clorox during the first quarter worth about $58,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.63% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have commented on CLX. Citigroup lowered their target price on Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Wells Fargo & Company lowered their target price on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research note on Thursday, September 25th. Barclays lowered their target price on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, September 30th. JPMorgan Chase & Co. reduced their price target on Clorox from $135.00 to $127.00 and set a “neutral” rating on the stock in a report on Friday. Finally, The Goldman Sachs Group reduced their price target on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a report on Wednesday, October 1st. One research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of $131.64.

Clorox Stock Performance

NYSE:CLX opened at $120.51 on Tuesday. The stock has a market cap of $14.67 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock’s 50-day moving average is $122.14 and its 200-day moving average is $128.40. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the prior year, the business posted $1.82 earnings per share. The firm’s revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be issued a $1.24 dividend. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.1%. Clorox’s dividend payout ratio is presently 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.